Second, improving cost-effectiveness remains critical
N-acetylcysteine (NAC) and acetyl-L-carnitine (ALC) are two supplements that have already been found effective in treating psychiatric conditions
In early 2026, Roche paid $100 million to secure a non-exclusive patent licence from Structures subsidiary Gasherbrum Bio, covering intellectual property relevant to CT-996, the oral GLP-1 compound Roche acquired through its $2.7 billion buyout of Carmot Therapeutics in late 2023
SeekPeptides members get access to the latest research updates, detailed protocol guides, and a community of experienced researchers who share real-world outcomes from their protocols
Morgan Growth, Goldman Growth) Growth investors decide which digital health models become dominant platforms in GLP-1 care
miR-330 alleviates dextran sodium sulfate-induced ulcerative colitis through targeting IRAK1 in rats